Table of Content



Introduction
Non-Small Cell Lung Cancer - Overview
Non-Small Cell Lung Cancer - Therapeutics Development
Non-Small Cell Lung Cancer - Therapeutics Assessment
Non-Small Cell Lung Cancer - Companies Involved in Therapeutics Development
Non-Small Cell Lung Cancer - Drug Profiles
Non-Small Cell Lung Cancer - Dormant Projects
Non-Small Cell Lung Cancer - Discontinued Products
Non-Small Cell Lung Cancer - Product Development Milestones
Appendix



List of Figures



Number of Products under Development for Non-Small Cell Lung Cancer, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables



Number of Products under Development for Non-Small Cell Lung Cancer, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Number of Products by Stage and Molecule Type, H1 2020 (Contd..1), H1 2020
Non-Small Cell Lung Cancer - Pipeline by 3SBio Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by 4D Pharma Plc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by 4SC AG, H1 2020
Non-Small Cell Lung Cancer - Pipeline by A&G Pharmaceutical Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2020
Non-Small Cell Lung Cancer - Pipeline by AbbVie Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Ability Pharmaceuticals SL, H1 2020
Non-Small Cell Lung Cancer - Pipeline by ABM Therapeutics Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by AC Bioscience SA, H1 2020
Non-Small Cell Lung Cancer - Pipeline by ACEA Therapeutics Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Achilles Therapeutics Ltd, H1 2020
Non-Small Cell Lung Cancer - Pipeline by AcuityBio Corp, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Adaptimmune Therapeutics Plc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by ADC Therapeutics SA, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Aduro BioTech Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Advanced BioDesign, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Advaxis Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Advenchen Laboratories LLC, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Adze Biotechnology Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Agenus Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Agilvax Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Agios Pharmaceuticals Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by AIM ImmunoTech Inc, H1 2020
Non-Small Cell Lung Cancer - Pipeline by Akeso Inc, H1 2020